Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: Implications for the effects of Δ 9-tetrahydrocannabinol on spatial memory

Neuropsychopharmacology

Volumn 36, Issue 2, 2011, Pages 472-487

  Sousa, Vasco C ^a,b   Assaife Lopes, Natália ^a,b   Ribeiro, Joaquim A ^a,b   Pratt, Judith A ^c   Brett, Ros R ^c   Sebastião, Ana M ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

adenosine; caffeine; cannabinoid; hippocampus; memory; THC

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (4,4 DIPHENYL 3 BUTENYL)NIPECOTIC ACID; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID; 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; CAFFEINE; CANNABINOID 1 RECEPTOR; GLUTAMIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; TETRAHYDROCANNABINOLIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG PENETRATION; FOOD INTAKE; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; SPATIAL MEMORY; SYNAPTIC TRANSMISSION;

ADENOSINE A1 RECEPTOR ANTAGONISTS; ANIMALS; CAFFEINE; CHRONIC DISEASE; HIPPOCAMPUS; MALE; MEMORY; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; PSYCHOTROPIC DRUGS; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A1; RECEPTOR, CANNABINOID, CB1; TETRAHYDROCANNABINOL;

EID: 78650173274     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2010.179     Document Type: Article

References (82)

1. Angelucci MEM, Cesário C, Hiroi RH, Rosalen PL, Da Cunha C (2002). Effects of caffeine on learning and memory in rats tested in the Morris water maze. Braz J Med Biol Res 35: 1201-1208.
2. Assaife-Lopes N, Sousa VC, Pereira DB, Ribeiro JA, Chao MV, Sebastião AM (2010). Activation of adenosine A2A receptors induces TrkB translocation and increases BDNF-mediated phospho-TrkB localization in lipid rafts: implications for neuromodulation. J Neurosci 30: 8468-8480.
3. Barone JJ, Roberts HR (1996). Caffeine consumption. Food Chem Toxicol 34: 119-129.
4. Baumgold J, Nikodijevic O, Jacobson KA (1992). Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding. Biochem Pharmacol 43: 889-894.
5. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
6. 35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. J Biol Chem 273: 16865-16873.
7. Cannizzaro C, D'Amico M, Preziosi P, Martire M (2006). Presynaptic effects of anandamide and WIN55,212-2 on glutamatergic nerve endings isolated from rat hippocampus. Neurochem Int 48: 159-165.
8. Carriba P, Ortiz O, Patkar K, Justinova Z, Stroik J, Themann A et al (2007). Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids. Neuropsychopharmacology 32: 2249-2259.
9. Castro CA, Hogan JB, Benson KA, Shehata CW, Landauer MR (1995). Behavioral effects of vehicles: DMSO, ethanol, Tween-20, Tween-80, and emulphor-620. Pharmacol Biochem Behav 50: 521-526.
10. Chen G, Chen KS, Knox J, Inglis J, Bernard A, Martin SJ et al (2000). A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 408: 975-979.
11. Cinar R, Freund TF, Katona I, Mackie K, Szucs M (2008). Reciprocal inhibition of G-protein signaling is induced by CB(1) cannabinoid and GABA(B) receptor interactions in rat hippocampal membranes. Neurochem Int 52: 1402-1409.
12. Consroe P, Jones B, Laird H (1976). EEG and behavioral effects of delta9-tetrahydrocannabinol in combination with stimulant drugs in rabbits. Psychopharmacology 50: 47-52.
13. 3H] gamma-aminobutyric acid release by kainate receptor activation in rat hippocampal synaptosomes. Eur J Pharmacol 323: 167-172.
14. Cunha RA, Constantino MD, Ribeiro JA (1999). G protein coupling of CGS 21680 binding sites in the rat hippocampus and cortex is different from that of adenosine A1 and striatal A2A receptors. Naunyn Schmiedebergs Arch Pharmacol 359: 295-302.
15. Cunha RA, Ribeiro JA (2000). Purinergic modulation of [(3)H]GABA release from rat hippocampal nerve terminals. Neuropharmacology 39: 1156-1167.
16. 3H]-GABA release from rat hippocampal nerve terminals. Neurosci Lett 430: 207-212.
17. 3H]GABA from synaptosomes isolated from the rat hippocampus. Neurochem Res 29: 1553-1561.
18. Daly JW, Fredholm BB (1998). CaffeineFan atypical drug of dependence. Drug Alcohol Depend 51: 199-206.
19. Dar MS (2000). Cerebellar CB(1) receptor mediation of Delta(9)-THC-induced motor incoordination and its potentiation by ethanol and modulation by the cerebellar adenosinergic A(1) receptor in the mouse. Brain Res 864: 186-194.
20. Dar MS, Mustafa SJ (2002). Acute ethanol/cannabinoid-induced ataxia and its antagonism by oral/systemic/intracerebellar A1 adenosine receptor antisense in mice. Brain Res 957: 53-60.
21. Daumas S, Betourne A, Halley H, Wolfer DP, Lipp H-P, Lassalle J-M et al (2007). Transient activation of the CA3 Kappa opioid system in the dorsal hippocampus modulates complex memory processing in mice. Neurobiol Learn Mem 88: 94-103.
22. DeSanty KP, Dar MS (2001). Involvement of the cerebellar adenosine A(1) receptor in cannabinoid-induced motor incoor-dination in the acute and tolerant state in mice. Brain Res 905: 178-187.
23. Dunwiddie TV, Fredholm BB (1989). Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus. J Pharmacol Exp Ther 249: 31-37.
24. Dunwiddie TV, Masino SA (2001). The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24: 31-55.
25. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA et al (1994). Nomenclature and classification of purinoceptors. Pharmacol Rev 46: 143-156.
26. Fredholm BB, Bättig K, Holmisén J, Nehlig A, Zvartau EE (1999). Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51: 83-133.
27. Freund TF, Buzsáki G (1996). Interneurons of the hippocampus. Hippocampus 6: 347-470.
28. Freund TF, Katona I (2007). Perisomatic inhibition. Neuron 56: 33-42.
29. Gasior M, Jaszyna M, Peters J, Goldberg SR (2000). Changes in the ambulatory activity and discriminative stimulus effects of psychostimulant drugs in rats chronically exposed to caffeine: effect of caffeine dose. J Pharmacol Exp Ther 295: 1101-1111.
30. Hájos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I et al (2000). Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 12: 3239-3249.
31. Herkenham M, Lynn A, Little M, Johnson M, Melvin L, de Costa B et al (1990). Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87: 1932-1936.
32. Hoffman AF, Laaris N, Kawamura M, Masino SA, Lupica CR (2010). Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors. J Neurosci 30: 545-555.
33. Hoffman AF, Lupica CR (2000). Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J Neurosci 20: 2470-2479.
34. Hooper N, Fraser C, Stone TW (1996). Effects of purine analogues on spontaneous alternation in mice. Psychopharmacology (Berl) 123: 250-257.
35. Howlett AC (2005). Cannabinoid receptor signaling. Handb Exp Pharmacol 168: 53-79.
36. Jacobson KA, von Lubitz DK, Daly JW, Fredholm BB (1996). Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol Sci 17: 108-113.
37. Jeong H-J, Jang I-S, Nabekura J, Akaike N (2003). Adenosine A1 receptormediated presynaptic inhibition of GABAergic transmission in immature rat hippocampal CA1 neurons. J Neurophysiol 89: 1214-1222.
38. Justinova Z, Ferré S, Barnes C, Wertheim CE, Pappas LA, Goldberg SR et al (2009). Effects of chronic caffeine exposure on adenosinergic modulation of the discriminative-stimulus effects of nicotine, methamphetamine, and cocaine in rats. Psychopharmacology 203: 355-367.
39. Katona I, Sperlágh B, Maglóczky Z, Sántha E, Köfalvi A, Czirják S et al (2000). GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience 100: 797-804.
40. Katona I, Sperlágh B, Śk A, Käfalvi A, Vizi ES, Mackie K et al (1999). Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippo-campal interneurons. J Neurosci 19: 4544-4558.
41. Katona I, Urbán GM, Wallace M, Ledent C, Jung K-M, Piomelli D et al (2006). Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26: 5628-5637.
42. Kawamura Y, Fukaya M, Maejima T, Yoshida T, Miura E, Watanabe M et al (2006). The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci 26: 2991-3001.
43. Köfalvi (2008). Alternative interacting sites and novel receptors for cannabinoid ligands. In: Köfalvi A (ed). Cannabinoids and the Brain. Springer: New York, pp 131-160.
44. 2+ levels and transmitter release in the hippocampus. Br J Pharmacol 151: 551-563.
45. Kouznetsova M, Kelley B, Shen M, Thayer SA (2002). Desensitiza-tion of cannabinoid-mediated presynaptic inhibition of neuro-transmission between rat hippocampal neurons in culture. Mol Pharmacol 61: 477-485.
46. Lambert NA, Teyler TJ (1991). Adenosine depresses excitatory but not fast inhibitory synaptic transmission in area CA1 of the rat hippocampus. Neurosci Lett 122: 50-52.
47. Leggett T (2006). A review of the world cannabis situation. Bull Narc 58: 1-155.
48. Li H, Henry JL (2000). Adenosine action on interneurons and synaptic transmission onto interneurons in rat hippocampus in vitro. Eur J Pharmacol 407: 237-244.
49. Lichtman AH, Varvel SA, Martin BR (2002). Endocannabinoids in cognition and dependence. Prostaglandins Leukot Essent Fatty Acids 66: 269-285.
50. Lopes LV, Cunha RA, Kull B, Fredholm BB, Ribeiro JA (2002). Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition. Neuroscience 112: 319-329.
51. McMahon HT, Foran P, Dolly JO, Verhage M, Wiegant VM, Nicholls DG (1992). Tetanus toxin and botulinum toxins type A and B inhibit glutamate, gamma-aminobutyric acid, aspartate, and met-enkephalin release from synaptosomes. Clues to the locus of action. J Biol Chem 267: 21338-21343.
52. Németh B, Ledent C, Freund TF, Hájos N (2008). CB1 receptor-dependent and -independent inhibition of excitatory postsynap-tic currents in the hippocampus by WIN 55,212-2. Neuropharmacology 54: 51-57.
53. Neu A, Földy C, Soltesz I (2007). Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecysto-kinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus. J Physiol 578(Part 1): 233-247.
54. Ochiishi T, Chen L, Yukawa A, Saitoh Y, Sekino Y, Arai T et al (1999). Cellular localization of adenosine A1 receptors in rat forebrain: immunohistochemical analysis using adenosine A1 receptor-specific monoclonal antibody. J Comp Neurol 411: 301-316.
55. Ohno M, Watanabe S (1996). Working memory failure by stimulation of hippocampal adenosine A1 receptors in rats. Neuroreport 7: 3013-3016.
56. Pertwee RG (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol 153: 199-215.
57. Pertwee RG, Stevenson LA, Elrick DB, Mechoulam R, Corbett AD (1992). Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br J Pharmacol 105: 980-984.
58. Petitet F, Jeantaud B, Bertrand P, Imperato A (1999). Cannabinoid penetration into mouse brain as determined by ex vivo binding. Eur J Pharmacol 374: 417-421.
59. Phelan P, Gordon-Weeks PR (1997). Isolation of synaptosomes, growth cones, and their subcellular components. In: Turner AJ, Bachelard HS (eds). Neurochemistry, A Practical Approach, 2nd edn. Oxford University Press: Oxford. pp 1-36.
60. Puighermanal E, Marsicano G, Busquets-Garcia A, Lutz B, Maldonado R, Ozaita A (2009). Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat Neurosci 12: 1152-1158.
61. Raiteri L, Raiteri M (2000). Synaptosomes still viable after 25 years of superfusion. Neurochem Res 25: 1265-1274.
62. Raiteri M, Angelini F, Levi G (1974). A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol 25: 411-414.
63. Ribeiro JA, Sebastião AM (2010). Caffeine and adenosine. J Alzheimers Dis 20(Suppl 1): S3-15.
64. Ribeiro JA, Sebastião AM, de Mendonça A (2002). Adenosine receptors in the nervous system: pathophysiological implications. Progr Neurobiol 68: 377-392.
65. Robbe D, Buzsáki G (2009). Alteration of theta timescale dynamics of hippocampal place cells by a cannabinoid is associated with memory impairment. J Neurosci 29: 12597-12605.
66. Robbe D, Montgomery SM, Thome A, Rueda-Orozco PE, Mcnaughton BL, Buzsaki G (2006). Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nat Neurosci 9: 1526-1533.
67. Rossi S, Chiara VD, Musella A, Mataluni G, Sacchetti L, Siracusano A et al (2009). Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects. Neuropharmacology 56: 590-597.
68. Sebastião AM, Stone TW, Ribeiro JA (1990). The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines. Br J Pharmacol 101: 453-459.
69. Selley DE, Cassidy MP, Martin BR, Sim-Selley LJ (2004). Long-term administration of Delta9-tetrahydrocannabinol desensitizes CB1-, adenosine A1-, and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellum. Mol Pharmacol 66: 1275-1284.
70. Serpa A, Ribeiro JA, Sebastião AM (2009). Cannabinoid CB(1) and adenosine A(1) receptors independently inhibit hippocampal synaptic transmission. Eur J Pharmacol 623: 41-46.
71. Shen M, Thayer SA (1998). The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptormediated and direct pathways in cultured rat hippocampal neurons. Brain Res 783: 77-84.
72. Shi D, Nikodijevic O, Jacobson KA, Daly JW (1993). Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain. Cell Mol Neurobiol 13: 247-261.
73. Shi D, Nikodijevic O, Jacobson KA, Daly JW (1994). Effects of chronic caffeine on adenosine, dopamine and acetylcholine systems in mice. Arch Int Pharmacodyn Ther 328: 261-287.
74. Sloviter RS, Ali-Akbarian L, Elliott RC, Bowery BJ, Bowery NG (1999). Localization of GABA(B) (R1) receptors in the rat hippocampus by immunocytochemistry and high resolution autoradiography, with specific reference to its localization in identified hippocampal interneuron subpopulations. Neuropharmacology 38: 1707-1721.
75. Straiker AJ, Borden CR, Sullivan JM (2002). G-protein alpha subunit isoforms couple differentially to receptors that mediate presynaptic inhibition at rat hippocampal synapses. J Neurosci 22: 2460-2468.
76. Tebano MT, Martire A, Chiodi V, Pepponi R, Ferrante A, Domenici MR et al (2009). Adenosine A2A receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum. J Neurochem 110: 1921-1930.
77. Varvel SA, Anum E, Niyuhire F, Wise LE, Lichtman AH (2005). Delta(9)-THC-induced cognitive deficits in mice are reversed by the GABA(A) antagonist bicuculline. Psychopharmacology 178: 317-327.
78. Varvel SA, Lichtman AH (2002). Evaluation of CB1 receptor knockout mice in the Morris water maze. J Pharmacol Exp Ther 301: 915-924.
79. Von Lubitz DK, Paul IA, Bartus RT, Jacobson KA (1993). Effects of chronic administration of adenosine A1 receptor agonist and antagonist on spatial learning and memory. Eur J Pharmacol 249: 271-280.
80. Wilson RI, Nicoll RA (2001). Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410: 588-592.
81. Wise LE, Thorpe AJ, Lichtman AH (2009). Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol. Neuropsychopharmacology 34: 2072-2080.
82. Yoon KW, Rothman SM (1991). Adenosine inhibits excitatory but not inhibitory synaptic transmission in the hippocampus. J Neurosci 11: 1375-1380.